The power of information and contraceptive choice in a family planning setting in Mexico

Sexually Transmitted Infections

Volumn 76, Issue 4, 2000, Pages 277-281

  Lazcano Ponce, E C ^a   Conde Glez, C J ^a   Sloan, N L ^b   Winikoff, B ^b   Coggins, C ^b   Langer, A ^c   Heimburger, A ^c   Salmeron, J ^d  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b POPULATION COUNCIL   (United States)

^c Population Council   (Mexico)

^d Instituto Mexicano de Seguro Social   (Mexico)

Author keywords

Contraception; Reproductive health; Sexually transmitted diseases

Indexed keywords

ADULT; ARTICLE; CHLAMYDIASIS; CONTRACEPTION; CONTROLLED STUDY; EVALUATION; FAMILY PLANNING; FEMALE; GONORRHEA; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MEXICO; PATIENT EDUCATION; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; CHLAMYDIA INFECTIONS; CHOICE BEHAVIOR; CONTRACEPTION; FAMILY PLANNING SERVICES; FEMALE; GONORRHEA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTRAUTERINE DEVICES; MEXICO; PATIENT ACCEPTANCE OF HEALTH CARE; REGRESSION ANALYSIS; SEX EDUCATION; SEXUALLY TRANSMITTED DISEASES;

EID: 0033811638     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.76.4.277     Document Type: Article

References (23)

1. 1 Demographic Health Survey. Encuesta National sobre Fecundidad y Salud 1987. Direccion General de Planificacion Familiar, México, DF, Institute for Resource Development Macro Systems Inc, Maryland, 1989.
2. 2 Farley TMM, Rosenberg MJ, Rowe P, et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992;339:785-8.
3. 3 Kooiker CH, Scutchfield FD. Barriers to prescribing the Copper T 380A intrauterine device by physicians. West J Med 1990;153:279-82.
4. 4 Lee NC, Rubin GL, Borucki R. The intrauterine device and pelvic inflammatory disease revisited: new results from the women's health study. Obstet Gynecol 1988;72:1-6.
5. 5 Rosenfield A, Peterson H, Tyler CW. Current trends - IUD safety: report of a nationwide survey. MMWR 1997;46: 960-74.
6. 6 Rivera R. Is there an effect of the IUD string in the development of pelvic inflammatory disease in IUD users? In: Bardin CW, Mishell DR Jr, ed. Proceedings from the Fourth International Conference on IUDs. Oxford: Butterworth-Heinemann, 1994:171-8.
7. 7 Barnett B. Key precautions minimize PID risk. Network 1996;16:11-15.
8. 8 Dry HW. A review of the association between intrauterine devices and acute pelvic inflammatory disease. J Reprod Med 1978;20:200-4.
9. 9 Plummer FA, Laga M, Brunham RC, et al. Postpartum upper genital tract infection in Nairobi, Kenya: epidemiology, etiology and risk factors. J Infect Dis 1987;156:92-8.
10. 10 IUD update signals renaissance for long-term contraceptive method. Contraceptive Technology Update 1998;19:17-20.
11. 11 World Health Organisation. Mechanism of action, safety and efficacy of intrauretine devices. Technical Report Series 753. Geneva: WHO, 1987.
12. 12 Faúndes A, Telles E, de Lourdes Cristofoletti M, et al. The risk of inadvertent intrauterine device insertion in women carriers of endocemcal Chlamydia trachomatis. Contraception 1988;58:105-9.
13. 13 Gerbase AC, Rowley JT, Heymann DHL, et al. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Inf 1998;74:S12-16.
14. 14 Population Reports. IUDs - An Update, Series B, Number 6. December 1995:1-25.
15. 15 Pathfinder International. Indicadores básions sobre planificación familiar en la fase intermedia de la SDES: Estrategias de Apoyo para la Expansión de la Prestación de Servicios. Series: Cuadernos de Trabajo 2, Mexico DF, 1996:15-17.
16. 16 Dallabetta GA, Gerbase AC, Holmes KK. Problems, Solutions, and challenges in syndromic management of sexually transmitted diseases. Sex Transm Inf 1998;74;S1-12.
17. 17 Bourgeois A, Henzel D, Dibanga G, et al. Prospective evaluation of a flow chart using a risk assessment for the diagnosis of STDs in primary healthcare centres in Libreville, Gabon. Sex Trans Inf 1998;74 (Suppl 1):S128-31.
18. 18 Braddick M, Ndinya-Achola J, Mirza N, et al. Towards developing a diagnostic algorithm for Chlamydia trachomatis and Neisseria gonorrhoeae cervicitis in pregnancy. Genitourin Med 1990;66:62-5.
19. 19 Ronsmans C, Bulut A, Yolsal N, et al. Clinical algorithms for the screening of Chlamydia trachomatis in Turkish women. Genitourin Med 1996;72:182-6.
20. 20 Costello Daly C, Maggwa N, Mati JK, et al. Risk factors for gonorrhoea, syphilis, and trichomonas infections among women attending family planning clinics in Nairobi, Kenya. Genitourin Med 1994;70:155-61.
21. 21 Vuylsteke B, Laga M, Alary M, et al. Clinical algorithms for the screening of women for gonococcal and chlamydial infection: evaluation of pregnant women and prostitutes in Zaire. Clin Infect Dis 1993;17:82-8.
22. 22 Iwen PC, Walker RA, Warren KL, et al. Evaluation of a nucleid acid-based test (Pace 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens. J Clin Microbiol 1995;33: 2597-1.
23. 23 Chernesky MA. How can industry, academia, public health authorities, and sexually transmitted diseases diagnostics initiative work together to help control STD in developing countries? Sex Transm Dis 1997;24:61-3.